PIPages
Labs

Tracy Hagemann

University of Wisconsin-Madison, WI·Neuroscience

Why do some children with a rare brain disease stop growing and keep vomiting, even when they are fed? Alexander disease is a severe neurodegenerative disorder caused by mutations in GFAP (glial fibrillary acidic protein), a structural protein made by astrocytes, the star-shaped support cells of the brain.

Fields

Neuroscience

Medicine & Clinical Research

Genetics

Topics

Alexander disease

AxD

astrocytes

Grants
1 known grant, through Jun 2027

What they work on

  1. Test whether GDF15 levels track failure-to-thrive symptoms in Gfap+/R237H rats by lowering GFAP with antisense oligonucleotides and measuring GDF15, GFRAL neuron activation and weight gain.
  2. Measure GDF15 in spinal fluid and plasma from Alexander disease patients in a natural history study and compare it with vomiting, growth and MRI lesion locations.
  3. Determine whether the integrated stress response, a cellular alarm program, drives GDF15 in astrocytes by altering it with drugs in rats and mapping cells with single-nucleus and spatial transcriptomics.
  4. Test whether GDF15 is the main cause of failure to thrive by blocking its receptor GFRAL with antibodies or knocking down GDF15 in the rat brainstem.

More about the research

The mutant protein clumps inside astrocytes and damages them. Many patients show failure to thrive, meaning poor weight gain and growth, along with frequent vomiting. Current treatments, such as nutritional supplements and feeding tubes, are invasive and often do not work.

Why it matters

Children and adults with Alexander disease often suffer from vomiting and poor growth that feeding tubes and supplements do not fix. If GDF15 drives these symptoms, blocking it or its receptor could offer a new way to prevent them, and GDF15 could serve as a biomarker. Insight into how stressed astrocytes affect the body may also inform other disorders with abnormal astrocytes, such as Alzheimer's and Parkinson's disease.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Failure to thrive in Alexander disease

NIH · Jul 2025 – Jun 2027

Closest labs

Stephen Liberles

Harvard University, MA·Neuroscience

Pinpoint where the NPY receptor NPY5R acts to let hunger boost attraction to food odors, testing whether it works in PVT-projecting piriform cortex neurons, using Cre-based Npy5r knockout and rescue mice.

Charles Brown

Stanford University, CA·Medicine & Clinical Research

Test whether cerebrospinal fluid markers of blood-brain barrier leak, inflammation, and neuron and astrocyte injury — including the CSF/blood albumin ratio, cytokines, neurofilament light and glial fibrillary acidic protein — are associated with delirium after aortic surgery in 180 patients with CSF drains.

Seunghye Han

Northwestern University, IL·Medicine & Clinical Research

Test whether a raised mitochondrial NADH/NAD+ ratio and the protein DELE1 are needed to activate the integrated stress response that blocks AT2-to-AT1 lung cell maturation when mitochondrial complex I is lost.

The school

University of Wisconsin-Madison: 91 labs on PI Pages, $1.9B a year on research, 854 research doctorates a year.

More about University of Wisconsin-Madison

Reach out

A start for your email. Fill in the brackets.